BiotechTube
Home/GlycoTherapeutics/Emiel Rossing
ER

Emiel Rossing

Head of Preclinical Development

GlycoTherapeutics

Therapeutic Areas

OncologyInfectious Disease

GlycoTherapeutics Pipeline

DrugIndicationPhase
Undisclosed Glycan-Disruption ProgramOncology (Immunotherapy combination)Pre-clinical

Leadership Team at GlycoTherapeutics

DJ
Dr. Johan Pijnenborg
CEO
NE
Nienke Eerden
Project Leader Medicinal Chemistry
DL
Dr. Leendert van den Bos
Head of Business Development
DT
Dr. Thomas Boltje
Scientific Advisor
DC
Dr. Christian Büll
Scientific Advisor
View full GlycoTherapeutics profile